"
Team:Cornell/Project
From 2010.igem.org
(Difference between revisions)
(Prototype team page) |
Bammarata89 (Talk | contribs) (→Overall project) |
||
| Line 46: | Line 46: | ||
== '''Overall project''' == | == '''Overall project''' == | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| + | The first portion of this project involves tracking antigens by means of non-toxic and non-immunogenic bacterial outer membrane vesicles through biotinylated ClyA surface proteins, single-chain antibody fragments, and contrast agents fused with streptavidin. | ||
| + | The second part of this project involves disrupting the localization of colon cancer cell inner membrane proteins through use endogenously expressed RNA aptamers. | ||
== Project Details== | == Project Details== | ||
Latest revision as of 21:36, 16 July 2010
This is a template page. READ THESE INSTRUCTIONS.
You are provided with this team page template with which to start the iGEM season. You may choose to personalize it to fit your team but keep the same "look." Or you may choose to take your team wiki to a different level and design your own wiki. You can find some examples HERE.
You MUST have a team description page, a project abstract, a complete project description, a lab notebook, and a safety page. PLEASE keep all of your pages within your teams namespace.
| You can write a background of your team here. Give us a background of your team, the members, etc. Or tell us more about something of your choosing. | File:Cornell logo.png 200px |
|
Tell us more about your project. Give us background. Use this is the abstract of your project. Be descriptive but concise (1-2 paragraphs) | File:Cornell team.png Your team picture |
| Team Example |
| Home | Team | Official Team Profile | Project | Parts Submitted to the Registry | Modeling | Notebook | Safety |
|---|
Contents |
Overall project
The first portion of this project involves tracking antigens by means of non-toxic and non-immunogenic bacterial outer membrane vesicles through biotinylated ClyA surface proteins, single-chain antibody fragments, and contrast agents fused with streptavidin. The second part of this project involves disrupting the localization of colon cancer cell inner membrane proteins through use endogenously expressed RNA aptamers.
